Oxetoron

Template:Oxetoron Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

For patient information, click here.

Oxetoron

Ball-and-stick model
Clinical data
AHFS/Drugs.com	International Drug Names
Pregnancy category	AU: <! -- A / B1 / B2 / B3 / C / D / X --> US: <! -- A / B / C / D / X -->
ATC code	N02CX06 (WHO)
Legal status
Legal status	AU: <! -- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled--> CA: <! -- Schedule I, II, III, IV, V, VI, VII, VIII --> UK: <! -- GSL, P, POM, CD, or Class A, B, C --> US: <! -- OTC / Rx-only / Schedule I, II, III, IV, V -->
Identifiers
IUPAC name (3Z)-3-[1]benzofuro[3,2-c][1]benzoxepin-6(12H)-ylidene-N,N-dimethylpropan-1-amine
CAS Number	26020-55-3 Y
PubChem CID	6436540
UNII	T3XOS33TIQ
KEGG	D08312 Y
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C21H21NO2
Molar mass	319.40 g/mol
3D model (JSmol)	Interactive image
SMILES CN(C)CCC=C1C2=CC=CC=C2OCC3=C1OC4=CC=CC=C34
(verify)

Oxetorone is an antimigraine agent.

Association with hyperprolactinemia has been described.

References

Template:Antimigraine preparations